sNDA

Spectrum Pharma files Fusilev sNDA with FDA
Pharmaceutical Business Review
Tue, 01/4/11 - 10:06 am
Spectrum Pharmaceuticals
Fusilev
FDA
sNDA
colorectal cancer
GlaxoSmithKline Withdraws Avodart US New Drug Application
WSJ Online
Mon, 11/23/09 - 09:53 am
Avodart
prostate cancer
GSK
sNDA
FDA To Review Takeda’s sNDA For Velcade
Pharmaceutical Business Review
Fri, 09/4/09 - 07:48 am
Takeda
sNDA
Velcade
FDA
Multiple Myeloma
Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
PR Newswire
Wed, 06/3/09 - 08:35 am
Eli Lilly
Cymbalta
chronic pain
sNDA
Spectrum Pharmaceuticals Announces That FDA Has Accepted FUSILEV sNDA for Colorectal Cancer Indication
Yahoo
Thu, 03/26/09 - 07:51 am
Spectrum Pharmaceuticals
Fusilev
colon cancer
sNDA
FDA